Outcomes with Multi Parametric MRI (mpMRI) Compared to Diagnostic Transurethral Resection of Bladder Tumor (TURBT) in Patients with Suspected Muscle-Invasive Bladder Cancer - a Pilot Study
Details
This is a pilot, single arm, prospective study that aims to validate the accuracy of the VI-RADS score obtained via multi-parametric magnetic resonance imaging (mpMRI) compared to pathologic cancer stage obtained via diagnostic transurethral bladder tumor resection (TURBT) as well as compare the clinical and quality of life outcomes between these diagnostic modalities in patients with suspected muscle-invasive bladder cancer (MIBC).
Eligibility
You can join if...
Please note this may not be a complete list of eligibility criteria. We have included a few examples of
study criteria to help you better understand how your eligibility in the study will be determined; your study
team will go through the study eligibility criteria with you to verify if you qualify for participation in this
study.
Inclusion Requirements
You can participate in this study if you
Are 18 years of age or older
Have suspected muscle-invasive bladder cancer (MIBC) determined by cystoscopy
Exclusion Requirements
You cannot participate in this study if you
Have prior TURBT within 120 days
Have prior therapy for bladder cancer within 120 days